BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21557375)

  • 1. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
    Fanning SW; Horn JR
    Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global analysis of VHHs framework regions with a structural alphabet.
    Noël F; Malpertuy A; de Brevern AG
    Biochimie; 2016 Dec; 131():11-19. PubMed ID: 27613403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camelid heavy-chain variable domains provide efficient combining sites to haptens.
    Spinelli S; Frenken LG; Hermans P; Verrips T; Brown K; Tegoni M; Cambillau C
    Biochemistry; 2000 Feb; 39(6):1217-22. PubMed ID: 10684599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
    Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
    Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
    Desmyter A; Spinelli S; Payan F; Lauwereys M; Wyns L; Muyldermans S; Cambillau C
    J Biol Chem; 2002 Jun; 277(26):23645-50. PubMed ID: 11960990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.
    Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C
    FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
    Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K
    J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the non-hypervariable FR3 D-E loop in single-domain antibody recognition of haptens and carbohydrates.
    Henry KA; Hussack G; Kumaran J; Gilbert M; MacKenzie CR; Sulea T; Arbabi-Ghahroudi M
    J Mol Recognit; 2019 Nov; 32(11):e2805. PubMed ID: 31423671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
    Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
    Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and modeling of the variable region of camelid single-domain antibodies.
    Sircar A; Sanni KA; Shi J; Gray JJ
    J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and specificity of several triclocarban-binding single domain camelid antibody fragments.
    Tabares-da Rosa S; Wogulis LA; Wogulis MD; González-Sapienza G; Wilson DK
    J Mol Recognit; 2019 Jan; 32(1):e2755. PubMed ID: 30033524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity transfer to a human protein by CDR3 grafting of camelid VHH.
    Inoue H; Iihara A; Takahashi H; Shimada I; Ishida I; Maeda Y
    Protein Sci; 2011 Dec; 20(12):1971-81. PubMed ID: 21910150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.
    Al Qaraghuli MM; Ferro VA
    J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27862476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hapten-induced dimerization of a single-domain VHH camelid antibody.
    Sonneson GJ; Horn JR
    Biochemistry; 2009 Jul; 48(29):6693-5. PubMed ID: 19572722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.
    Kim HJ; McCoy MR; Majkova Z; Dechant JE; Gee SJ; Tabares-da Rosa S; González-Sapienza GG; Hammock BD
    Anal Chem; 2012 Jan; 84(2):1165-71. PubMed ID: 22148739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.